Home News Room

News Room

Tilray ontvangt licentie om medicinale cannabis te produceren in de Europese Unie

Bedrijf maakt investering van € 20 miljoen voor het bouwen van EU Campus en begint activiteiten dit jaar De EU Campus van Tilray wordt gevestigd in het BIOCANT Research Park in Cantanhede, Portugal, en zal GMP-kwaliteit medicinale cannabisproducten cultiveren, verwerken, verpakken en distribueren aan gekwalificeerde patiënten, apotheken en onderzoekers in de gehele Europese gemeenschappelijke markt. […]

Tilray reçoit une licence pour produire du cannabis thérapeutique dans l’Union européenne

L’entreprise annonce 20 millions € d’investissement pour créer un Campus européen et commence son exploitation cette année Situé dans le Parc de recherche BIOCANT à Cantanhede au Portugal, le Campus européen de Tilray cultivera, traitera, conditionnera et distribuera des produits à base de cannabis à usage thérapeutique, conformes aux normes BPF, et à destination des patients, pharmacies et […]

Tilray recibe la autorización para producir cannabis medicinal en la Unión Europea

La empresa anuncia una inversión de 20 millones de euros para construir un campus en la UE y comenzar a operar este año Situado en el parque de investigación BIOCANT en Cantanhede (Portugal), el campus de la UE cultivará, procesará, envasará y distribuirá productos del cannabis medicinal, elaborados siguiendo unas buenas prácticas de fabricación, a […]

Tilray ottiene l'autorizzazione alla produzione di cannabis ad uso medico nell'Unione Europea

La società annuncia un investimento di 20 milioni di euro nella costruzione di un campus nell’UE e l’avvio delle operazioni entro l’anno in corso Il Campus dell’UE di Tilray, ubicato nel parco di ricerca BIOCANT a Cantanhede, Portogallo, si occuperà della coltivazione, della lavorazione, dell’imballaggio e della distribuzione dei prodotti a base di cannabis ad […]

Tilray erhält Lizenz zum Anbau von Medizinalhanf in der EU

Das Unternehmen kündigt eine Investition in Höhe von 20 Mio. € für den Bau eines EU-Campus und die Aufnahme des Betriebs im laufenden Jahr an Im EU-Campus von Tilray, der sich im BIOCANT-Forschungspark im portugiesischen Cantanhede befindet, sollen Produkte aus GMP-gerechtem Medizinalhanf angebaut, verarbeitet, verpackt und an qualifizierte Patienten, Apotheken und Forschungseinrichtungen im europäischen Binnenmarkt vertrieben werden. […]

Tilray Receives License to Produce Medical Cannabis in the European Union

Company Announces €20 Million Investment to Build EU Campus and Begin Operations this Year Located in the BIOCANT Research Park in Cantanhede, Portugal, Tilray’s EU Campus will cultivate, process, package, and distribute GMP-grade medical cannabis products to qualified patients, pharmacies, and researchers throughout the European common market. Phased build-out of the EU Campus will begin […]

PharmaCyte Restructures Agreements with Austrianova to Strengthen Partnership

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has reached an agreement with Austrianova to restructure certain agreements between them pursuant to a Binding Term Sheet (Term Sheet). The […]

Leafbuyer Technologies Signs Deal with Another Leading Dispensary Chain in Colorado

Deal Adds Rocky Road Remedies to Leafbuyer’s Stable of Top-Brand Customers in Colorado DENVER–(BUSINESS WIRE)–Leafbuyer Technologies, Inc. (OTC: LBUY) (“Leafbuyer”), a leading cannabis technology platform, has announced a deal to provide a suite of services to Rocky Road Remedies. With six locations in Colorado, Rocky Road Remedies is one of the leading dispensary chains in Colorado. […]

CanniMed Therapeutics Inc. Announces 2017 Third Quarter Results Release Date

SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) announces that it plans to release its financial results for the three and nine months ended July 31, 2017 before markets open on Monday September 11, 2017. About CanniMed Therapeutics Inc. CanniMed is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian […]

Marley Natural Launches New STUDIO Line of Cannabis Flower in California

Responsibly cultivated herb artfully crafted by gifted producers LOS ANGELES–(BUSINESS WIRE)–Marley Natural, the official Bob Marley cannabis brand, today announced the debut of STUDIO, a new line of cannabis flower available in California. Inspired by the collaborations that brought Bob Marley’s music to life, Marley Natural STUDIO strains are masterpieces of modern indoor herb, created […]